Pfizer and BioNTech have applied to the Food and Drug Administration for emergency use authorization to administer their coronavirus vaccine to children ages 6 months to 5 years old, the companies announced Wednesday.
Sign up to stay connected
Get the top stories of the day around the DMV.
